TLR Therapeutics, Inc. has recently filed for an orphan drug status Phase II clinical trial with the US FDA on the treatment of myelodysplastic syndrome (MDS). About 30% of MDS cases advance to become cancer, specifically acute myeloid leukemia (AML). MDS is caused by the mutation of one or more gen...
Use this information to figure out if this company is an ideal customer for you.
951.662.3988
251 Little Falls Drive
Wilmington, 19808
11 - 50 Employees
$1M - $5M
linkedin.com/company/tlr-therapeutics
TLR Therapeutics's CEO is Stephen J McCormack
TLR Therapeutics's HQ is located at 251 Little Falls Drive, Wilmington
TLR Therapeutics's phone number is 951.662.3988
TLR Therapeutics's official website is tlrtx.com
TLR Therapeutics's revenue is $1M - $5M
TLR Therapeutics has 11 - 50 employees
TLR Therapeutics is in the industry of: Pharmaceuticals
